Phase II

Type: Keyphrase
Name: Phase II
First reported 23 hours ago - Updated 50 mins ago - 11 reports

Bristol-Myers Squibb (BMY) Rose To A New High On Phase 2 Study Results

Bristol-Myers Squibb (BMY: Quote) reported results from its Phase 2 study of Opdivo, an investigational PD-1 immune checkpoint inhibitor, in patients with advanced squamous cell non-small cell lung cancer Thursday morning. Bristol-Myers Squibb gapped ... [Published RTTNews.com - 1 hour ago]
First reported 17 hours ago - Updated 56 mins ago - 2 reports

Onxeo reports positive preliminary results from Validive Phase II trial for oral mucositis

French biopharmaceutical firm Onxeo has reported positive preliminary top-line results from its Phase II clinical trial of Validive (mucoadhesive buccal tablet MBT clonidine Lauriad) to prevent severe oral mucositis (OM). ... [Published PBR - News - 4 hours ago]
First reported 15 hours ago - Updated 15 hours ago - 3 reports

Federal Realty Launches Phase Two Of Pike & Rose

/PRNewswire/ --  Federal Realty Investment Trust (NYSE:FRT) announced today its plans to proceed with Phase II of Pike & Rose to meet the strong retail and residential demand at this…Click to Continue » ... [Published Rock Hill Herald - 15 hours ago]
First reported 23 hours ago - Updated 19 hours ago - 5 reports

Market Update (NYSE:BAX): Baxter’s Investigational 20% Subcutaneous Immunoglobulin Treatment Meets Efficacy and Tolerability Endpoints in Phase 2/3 Study

[Business Wire] – Baxter International Inc. presented the results of a Phase 2/3 study of its investigational 20 percent concentration subcutaneous immunoglobulin treatment for primary imRead more on this.Baxter International Inc. (BAX) , valued at $37.77B, ... [Published Jutia Group - 19 hours ago]
First reported 23 hours ago - Updated 23 hours ago - 4 reports

BIND Therapeutics Announces Availability of Abstract with Preliminary Data from Phase 2 Study of BIND-014 in Non-small Cell Lung Cancer

First reported Oct 30 2014 - Updated Oct 30 2014 - 4 reports

GW PHARMACEUTICALS : Starts Trial On Epidiolex For Dravet Syndrome

LONDON ( Alliance News ) - GW Pharmaceuticals PLC on Thursday said it has started a Phase 2/3 clinical trial on Epidiolex for the treatment of Dravet syndrome.Dravet is a treatment-resistant form of childhood epilepsy."The results of our open-label trial ... [Published 4 Traders - Oct 30 2014]
First reported Oct 29 2014 - Updated Oct 30 2014 - 2 reports

RTA opens main traffic diversion on Al Wasl Road on Friday

Dubai's Roads and Transport Authority (RTA) opens on Friday the main traffic diversion on Al Wasl Road in both directions, nearby Al Safa Park, stretching about half a kilometre and maintaining the same number of lanes to avoid disruption of the traffic ... [Published Emirates247 - Oct 29 2014]
First reported Oct 29 2014 - Updated Oct 29 2014 - 2 reports

Neuroderm Ltd announces positive topline results of phase II

3:01pm EDTNeuroderm Ltd:Says patients with moderate to severe Parkinson's disease who received continuous, subcutaneous doses of liquid levodopa/carbidopa (LD/CD) (ND0612L) exhibited clinically significant reduction in fluctuations of plasma levodopa ... [Published Reuters - Oct 29 2014]
Entities: Phase II, L-Dopa, Placebo
First reported Oct 29 2014 - Updated Oct 29 2014 - 2 reports

India bans plastic packaging for drug liquids

The country's drug ministry has identified drugs as an area for savings.The former FDA director of medical device compliance has petitioned the agency to make oral contraceptives over-the-counter.FDA commissioner Hamburg says agency wants to hasten medical ... [Published Medical Marketing And Media - Oct 29 2014]
Entities: Liquidation, Drugs, Plastics
First reported Oct 29 2014 - Updated Oct 29 2014 - 2 reports

A New Cancer Drug Worked In Over 50% Of Patients In A Phase II Trial

A new cancer drug benefited 51 percent of stage III and IV melanoma patients during a phase II trial, achieving complete response (total cancer disappearance) in 26 percent during the treatment period. That was all in just 16 weeks of treatment, suggesting ... [Published Austin American Statesman - Oct 29 2014]
First reported Oct 29 2014 - Updated Oct 29 2014 - 2 reports

Receptos rockets on positive mid-stage results for UC drug candidate

US discovery and development company Receptos (Nasdaq: RCPT) saw its shares rocket 47% to a new high, after it announced that TOUCHSTONE, the Phase II trial of RPC1063 in ulcerative colitis (UC), met its primary endpoint and all secondary endpoints with ... [Published Pharma Letter - Oct 29 2014]
First reported Oct 29 2014 - Updated Oct 29 2014 - 2 reports

Najib briefed on Battersea Power Station financing

DUBAI: Prime Minister Datuk Seri Najib Razak has been briefed today on Maybank Islamic Berhad's success to co-structure and underwrite Syndicated Islamic Facilities for Phase 3 of the Battersea Power Station (BPS) project in London.Of the total financing ... [Published New Straits Times - Oct 29 2014]

Quotes

...underlying business grew nearly 14 percent in the quarter excluding lipids," said Richard A Gonzalez, chairman and chief executive officer, AbbVie. "We exceeded our outlook for the quarter and have significantly raised our original 2014 guidance. In the fourth quarter, we look forward to the U S approval of our interferon-free HCV combination, which will further accelerate sales and earnings growth in 2015 and beyond."
"It's going to create a density back into the area that's going to be fabulous for all the business people here" Robert Greenberg, of ACME Furniture, said
"I've never known Cellceutix to take its foot off the gas pedal or fail to execute on its business plan. My addition to the team is intended to complement and support this approach and continue to grow shareholder value in a bid to have at least five different clinical trials in progress in 2015, a goal I believe we will attain."
JDwag writes, " Your hit pieces on Arena Pharmaceuticals ( ARNA ) and Rockwell Medical ( RMTI ) again shows what a total POS you are. The information isn't out there for 15 minutes and you're already slamming the data for your short friends. One day, you will get what's coming to you. "

More Content

All (6836) | News (5514) | Reports (3) | Blogs (1115) | Audio/Video (0) | Fact Sheets (27) | Press Releases (148)
sort by: Date | Relevance
AbbVie Reports Third-Quarter 2014 Financial Res... [Published Scottrade - 27 mins ago]
This is what Battersea Power Station will look ... [Published NewsRT.co.uk - 34 mins ago]
Changes Coming to Coliseum Site in New Haven [Published NBC Connecticut - 40 mins ago]
Stalled Utah Mixed-Use Development Re-Started w... [Published RENTV.com - 43 mins ago]
Market Update (NASDAQ:VRTX): Vertex to Present ... [Published Jutia Group - 1 hour ago]
Cellceutix's New Chief Operating Officer Dr. Ja... [Published Stockboard Media Inc. - 1 hour ago]
Bristol-Myers Squibb (BMY) Rose To A New High O... [Published RTTNews.com - 1 hour ago]
Lamboo Resources Limited, Quarterly Activities ... [Published Finance News Network - 1 hour ago]
Biotech Stock Mailbag: Prosensa, Sarepta, Arena... [Published TheStreet.com - 1 hour ago]
Dubai's DEWA awards USD55m deal to Swiss firm [Published MENAFN - 1 hour ago]
Firms hoping to cash in on 48,000 visits at Ben... [Published West Midlands Express & Star - 1 hour ago]
Biotech Stock Mailbag: Prosensa, Sarepta, Arena... [Published The Street Latest - 1 hour ago]
BMS' PD-1 blocker Opdivo aces lung cancer trial [Published PMLive - 1 hour ago]
The Lawyer Management Awards 2014: Best Major P... [Published The Lawyer - 2 hours ago]
Intercept to Report Third Quarter 2014 Results ... [Published Crawford Financial Planning - 2 hours ago]
BMS lung cancer drug scores in Phase II [Published Pharmafocus - 2 hours ago]
Institute Launches Platform to Support SMEs [Published AllAfrica.com - 2 hours ago]
Gastric Ulcers-Pipeline Insights, 2014 [Published Individual.com - 3 hours ago]
Japanese Mushroom Extract Eradicates Human Papi... [Published Nutrition Review - 3 hours ago]
Mushroom extract could treat HPV [Published Healthcare Learning Company - 3 hours ago]
RBI Grade B (General) Officers recruitment Phas... [Published India Today - 3 hours ago]
Onxeo reports positive preliminary results from... [Published PBR - News - 4 hours ago]
Burundi: Burundi Remote Monitoring Update - Oct... [Published ReliefWeb - Latest Updates - 4 hours ago]
Madagascar: Madagascar Remote Monitoring Update... [Published ReliefWeb - Latest Updates - 4 hours ago]
Sanmar Group plans to invest $150 mn in Egypt [Published Business Standard India - 4 hours ago]
Zimplats : reports 13% slump in output - The Zi... [Published 4 Traders - 4 hours ago]
SBI PO Associate Bank Exam 2014: Admit card rel... [Published India Today - 4 hours ago]
Valence short-lists debt funders [Published Mining Weekly - 4 hours ago]
Biotie interim report 1 January - 30 September ... [Published KGO - 5 hours ago]
Cousins Properties' (CUZ) CEO Lawrence Gellerst... [Published Seeking Alpha - 5 hours ago]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Onxeo reports positive preliminary results from... [Published PBR - News - 4 hours ago]
French biopharmaceutical firm Onxeo has reported positive preliminary top-line results from its Phase II clinical trial of Validive (mucoadhesive buccal tablet MBT clonidine Lauriad) to prevent severe oral mucositis (OM). ...
Burundi: Burundi Remote Monitoring Update - Oct... [Published ReliefWeb - Latest Updates - 4 hours ago]
Source: Forum on Early Warning and Early ResponseCountry: Burundi Normal Season A harvests expected to improve food availability country-wide Key Messages Season A 2015 planting is almost complete across the country. Average to above-average rainfall ...
Madagascar: Madagascar Remote Monitoring Update... [Published ReliefWeb - Latest Updates - 4 hours ago]
Source: Famine Early Warning System NetworkCountry: Madagascar Stressed food insecurity expected starting in October due to above-average food prices, debt Key Messages Near-average national rice production this year, along with a near-average ...
Onxeo S.A.: Positive Phase II preliminary resul... [Published Business Wire Health News - 18 hours ago]
PARIS & COPENHAGEN, Denmark--(BUSINESS WIRE)--Regulatory News: Onxeo S.A. (Paris:ONXEO) (NASDAQ OMX:ONXEO) (Euronext Paris, NASDAQ OMX Copenhagen: ONXEO), an innovative biopharmaceutical company specializing in the development of orphan oncology drugs, ...
Phase 2 Objective Response Rate and Survival Da... [Published Business Wire Health News - 23 hours ago]
PRINCETON, N.J.--(BUSINESS WIRE)--Phase 2 Objective Response Rate&Survival Data for Opdivo(nivolumab) in Heavily Pre-treated Advanced Squamous Cell Non-Small Cell Lung Cancer to be Presented at 2014 Chicago Multidisciplinary Symposium ...
1 2 3 4 5 6 7 8 9 10 ...

Press Releases

sort by: Date | Relevance
Federal Realty Launches Phase Two Of Pike & Rose [Published Financial Services - 16 hours ago]
NeoStem Announces Third Quarter 2014 Financial ... [Published GlobeNewswire: Acquisitions News - 16 hours ago]
Onxeo S.A.: Positive Phase II preliminary resul... [Published GlobeNewswire: Acquisitions News - 17 hours ago]
Recro Pharma Announces Dosing of First Patient ... [Published GlobeNewswire: Acquisitions News - Oct 29 2014]
Immunomedics Provides Update on Phase 2 Study o... [Published GlobeNewswire: Acquisitions News - Oct 29 2014]
1 2 3 4 5 6 7 8 9 10 ...
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.